Figure 1. Expression of AR, CD44/CD24 and let-7a and prognosis.
Immunohistochemical staining of AR positive. (A) and the negative control (B), original magnification ×200. ISH of let-7a positive (C) and the negative control (D), original magnification ×200. Double immunohistochemical staining of CD44-/CD24+ (E), CD44+/24-/low (F), CD44+/CD24+ (G) and CD44-/CD24- (H), original magnification ×400. DFS and OS curves about CD44+/24-/low (I and J), AR (K and L) and let-7a expression (M and N) status in 165 patients with invasive breast carcinoma.